Global Natamycin Market 2022-2026

Global Natamycin Market 2022-2026

Technavio has been monitoring the natamycin market and it is poised to grow by $ 12.35 mn during 2022-2026 progressing at a CAGR of 3.34% during the forecast period. Our report on the natamycin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for dairy and meat products, increased use in antifungal pharmaceutical products, and the long-lasting antifungal effect of natamycin.

The natamycin market analysis includes application segment and geographic landscape.

Technavio's natamycin market is segmented as below:

By Application

• food and beverages
• pharmaceuticals
• personal care
• others

By Geographical Landscape

• APAC
• North America
• Europe
• South America
• The Middle East and Africa

This study identifies the rising consumption of ready-to-eat food products as one of the prime reasons driving the natamycin market growth during the next few years. Also, an increase in the incidence of fungal infections, and natural preferred additives in the food industry will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the natamycin market covers the following areas:

• Natamycin market sizing
• Natamycin market forecast
• Natamycin market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading natamycin market vendors that include Beijing Oriental Rada Biotech Co. Ltd., ChihonBio Co. Ltd., Handary SA, Indukern SA, Koninklijke DSM NV, Meihua Holdings Group Co. Ltd., Novartis Pharmaceuticals Corp., Siveele BV, Fujian life come biochemistry Ltd., Zhejiang Silver Elephant Bio-Engineering Co. Ltd., and DuPont de Nemours Inc. Also, the natamycin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Companies Mentioned

Beijing Oriental Rada Biotech Co. Ltd., ChihonBio Co. Ltd., Handary SA, Indukern SA, Koninklijke DSM NV, Meihua Holdings Group Co. Ltd., Novartis Pharmaceuticals Corp., Siveele BV, Fujian lifecome biochemistry Ltd., Zhejiang Silver Elephant Bio Engineering Co. Ltd., DuPont de Nemours Inc.